Inhibrx, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for INBX, updated each market day.
INBX AI Sentiment
AI sees no strong directional signal for Inhibrx, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Inhibrx, Inc. Common Stock
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Sector
Exchange
Market Cap
$1,106,482,977
Cap Tier
Employees
110
Headquarters
LA JOLLA, CA
Listed Since
May 28, 2024
Website
INBX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INBX Volatility
Inhibrx, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
